Taiwan FDA registration 078a1d7080246ba486ffc6ed93699d34
Restylane Refyne
TW: 瑞絲朗-晶采(含利多卡因)
Taiwan·Risk Class 3·MD·Q-MED AB·Registered Jan 04, 2018 – Jan 04, 2028ActiveRegistration details
- Analysis ID
- 078a1d7080246ba486ffc6ed93699d34
- License Form
- Ministry of Health Medical Device Import No. 030309
- Customs Code
- DHA05603030901
Company information
- Manufacturer
- Q-MED AB
- Manufacturer Country
- Sweden
- Authorized Representative
- GALDERMA HONG KONG LIMITED, TAIWAN BRANCH
Product details
- Intended Use
- This product can be used to enhance the fullness of facial tissues. Recommended for the correction of moderate wrinkles such as nasolabial folds, depending on the area and tissue support to be treated, this product should be injected into the middle to deep dermis or subcutaneous tissue. Lidocaine is added to the product to reduce pain during therapeutic injections.
- Product Type (Level 1)
- I General and plastic surgical devices
- Product Type (Level 2)
- I0007 Hyaluronic acid implants
- Import Information
- Imported from abroad
Dates and status
- Registration Date
- Jan 04, 2018
- Expiry Date
- Jan 04, 2028
About this record
Access comprehensive regulatory information for Restylane Refyne in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 3 medical device is registered under number 078a1d7080246ba486ffc6ed93699d34 and manufactured by Q-MED AB. The authorized representative in Taiwan is GALDERMA HONG KONG LIMITED, TAIWAN BRANCH.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices